Abstract Treatment of BRAF(V600E) mutant melanoma by small molecule drugs that target
the BRAF or MEK kinases can be effective, but resistance develops invariably 1 , 2 . In …

Liver cancer remains difficult to treat, owing to a paucity of drugs that target critical dependencies
1 , 2 ; broad-spectrum kinase inhibitors such as sorafenib provide only a modest benefit …

BRAF(V600E) mutant melanomas treated with inhibitors of the BRAF and MEK kinases
almost invariably develop resistance that is frequently caused by reactivation of the mitogen …

Senescence is a cellular response to a variety of stress signals that is characterized by a
stable withdrawal from the cell cycle and major changes in cell morphology and physiology. …

Hepatocellular carcinoma (HCC)—the most common form of liver cancer—is an aggressive
malignancy with few effective treatment options 1 . Lenvatinib is a small-molecule inhibitor of …

Over the past two decades, elucidation of the genetic defects that underlie cancer has resulted
in a plethora of novel targeted cancer drugs. Although these agents can initially be highly …

Solar‐driven CO 2 methanation with water is an important route to simultaneously address
carbon neutrality and produce fuels. It is challenging to achieve high selectivity in CO 2 …

The ability of insulin to suppress gluconeogenesis in type II diabetes mellitus is impaired;
however, the cellular mechanisms for this insulin resistance remain poorly understood. To …

A truncated naturally occurring variant of the human receptor P2X 7 was identified in cancer
cervical cells. The novel protein (P2X 7-j ), a polypeptide of 258 amino acids, lacks the entire …

Senescence is a proliferation arrest that can result from a variety of stresses. Cancer cells
can also undergo senescence, but the stresses that provoke cancer cells to undergo …